Sumeyye Baser

Sumeyye Baser

Auto-generated profile, based on publicly available information

Sumeyye Baser

Faculty of Pharmacy, Department of Pharmaceutical Microbiology, Erzincan Binali Yıldırım University, Erzincan, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
ÖÇözgür çelebi
özgür çelebi
DÇDemet Çelebi
Demet Çelebi
SBSumeyye Baser
Sumeyye Baser
EAElif Aydın
Elif Aydın
ERErva Rakıcı
Erva Rakıcı
A. M. Abd El-AtyA. M. Abd El-Aty
A. M. Abd El-Aty

17 February 2024 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
DÇDemet Çelebi
Demet Çelebi
ÖÇözgür çelebi
özgür çelebi
ATAli Taghizadehghalehjoughi
Ali Taghizadehghalehjoughi
SBSumeyye Baser
Sumeyye Baser
EAElif Aydın
Elif Aydın
SYSerkan YILDIRIM
Serkan YILDIRIM

26 October 2023 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
DÇDemet Çelebi
Demet Çelebi
ÖÇözgür çelebi
özgür çelebi
EAElif Aydin
Elif Aydin
SBSumeyye Baser
Sumeyye Baser
MGMustafa Can Güler
Mustafa Can Güler
ATAli Taghizadehghalehjoughi
Ali Taghizadehghalehjoughi

1 January 2024 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
ÖÇözgür çelebi
özgür çelebi
DÇDemet Çelebi
Demet Çelebi
SBSumeyye Baser
Sumeyye Baser
AYAysegul Yilmaz
Aysegul Yilmaz
SYSerkan YILDIRIM
Serkan YILDIRIM
Background: Recent research has unveiled that approximately 50%-70% of patients afflicted with lung cancer also receive concurrent diagnoses of lung infections, most notably pneumonia. Among the critical multidrug-resistant pathogens frequently isolated from pneumonia-afflicted patients, Pseudomonas aeruginosa and Acinetobacter baumannii stand prominent. Here, we assessed the impact of antibiotics and vitamins on the lung cancer infection cell culture. Methods: The study delves into the antimicrobial properties of vitamins P, K, and E against A. baumannii and P. aeruginosa, employing the minimum inhibitory concentration method and scrutinizing biofilm formation within the A549 cell culture. Results: The combined application of vitamins and antibiotics exhibited a statistically significant effect on both the minimal inhibitory concentration values and biofilm formation (P < .05). Within the realm of fat-soluble vitamins, vitamins K and E, when integrated with antibiotics, revealed varying degrees of influence, with vitamin K displaying the most substantial fractional inhibitory concentration value. Vitamin E, on the other hand, demonstrated a comparatively weaker fractional inhibitory concentration than the other constituents. Nevertheless, it exhibited robust optical density and a pronounced capacity to inhibit biofilm formation. Moreover, among the vitamin groups, it is evident that vitamin E surpasses the efficacy of others (antibacterials affecting K < P < E). The collective application of all vitamins manifested the most potent fractional inhibitory concentration. Conclusion: The synergistic effects of vitamins with antibiotics, as evidenced in this study, may offer a promising alternative for treating multidrug-resistant A. baumannii and P. aeruginosa, subject to further investigation through molecular studies. Cite this article as: Celebi O, Celebi D, Baser S, Yilmaz A, Yildirim S. Vitamins can increase antibiotic efects against multidrug-resistant pseudomonas aeruginosa and acinetobacter baumannii in an in vitro infection model. Eurasian J Med., 2024;56(2):91-97.

25 March 2021 in Journal of Contemporary Medicine
Verified
Journal Article
Closed access
PDF file
SBSümeyye Başer
Sümeyye Başer
AIAynur Ismayil
Aynur Ismayil
SMSalih Maçin
Salih Maçin
Aim: Diagnosis of echinococcosis is based on clinical symptoms, imaging techniques and particularly on the detection of specific antibodies in serum specimens of patients. The aim of this study is retrospective evaluation of seropositivity from patients who is diagnosed as Cystic echinococcosis. Materials and Methods: In this study, the blood serum samples of patients, which were sent to the Medical Microbiology Laboratory from several clinics of the Selcuk University Medical Faculty Hospital between 01 January 2015- 01 July 2020, were evaluated in terms of Cystic echinococcosis by using indirect hemaglutination test. The results were evaluated with a cut off titer ≥160 of as recommended by the manufacturer. Results were evaluated by gender and ages. Results: Cystic echinococcosis (CE) was determined to be seropositive 332 (21.6%) of 1543 patient samples. Seropositivity was found in 226 (14,7%) of 933 female patients and in 106 (6,9%) of 610 male patients. Seropositivity was mostly seen in 21-40 age group. Conclusion: While there have been a number of animal studies, little information is available about the prevalence of Cystic echinococcosis in humans in Turkey. Cystic echinococcosis continues to be a majör public health problem in the Konya province. Large scale prevention and control programs should be implemented against this disease.

21 July 2025 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
MUMahmut Ucar
Mahmut Ucar
ÖÇözgür çelebi
özgür çelebi
DÇDemet Çelebi
Demet Çelebi
SBSumeyye Baser
Sumeyye Baser
MGMustafa Can Guler
Mustafa Can Guler
SYSerkan YILDIRIM
Serkan YILDIRIM
Sepsis is a life-threatening systemic inflammatory condition marked by a dysregulated host response to infection. The intestinal microbiota plays a pivotal role in maintaining immune homeostasis and epithelial barrier integrity, whereas dysbiosis significantly contributes to the pathogenesis of sepsis. This study investigates the effects of the Pseudomonas aeruginosa-derived metabolite Pyocyanin and the probiotic Saccharomyces boulardii (S. boulardii) on microbial composition and the TLR4/MyD88/NF-κB/NLRP3 signaling axis in a cecal ligation and puncture (CLP)-induced rat model of sepsis. The experimental design assessed the synergistic or antagonistic effects of single and combined treatments using molecular, microbiome, and immunohistochemical parameters to evaluate histopathological damage and microbial ecological dynamics. Seven experimental groups were established following CLP. Intra-abdominal Pyocyanin (10 nmol/g) and oral probiotic (10⁶ CFU/kg) treatments were administered either individually or in combination. Focused Ion Beam - Scanning Electron Microscopy (FIB-SEM) analyses revealed that the amorphous structure of Pyocyanin interacted with the surface of S. boulardii. Western blot analysis showed a 2.3-fold increase in TLR4/NF-κB expression in the CLP group (p ≤ 0.05), which synergistically rose to 4.5-fold with Pyocyanin (p ≤ 0.001), whereas probiotic treatment decreased expression levels by 35%. According to 16 S rRNA sequencing, Pyocyanin reduced α-diversity by increasing Lactobacillaceae abundance to 32.66% (Shannon index: 3.598 vs. 4.433 in control), while S. boulardii enhanced β-diversity by elevating Coriobacteriaceae (5.85%) and Prevotellaceae (10.63%) levels (Tables 2, 3 and 4). PCoA confirmed 41.7% Bray-Curtis dissimilarity between groups at the species level (PERMANOVA R²=0.38, p = 0.002). Histopathologically, severe hepatocyte necrosis (73.2 ± 6.1%, p = 0.0022) and a 4.2-fold increase in hepatic TGF-β expression were observed in the CLP group, whereas epithelial barrier damage was significantly attenuated in the probiotic groups. Immunofluorescence analysis revealed that combined treatment reduced Caspase-8 and TLR4 expression by 28% compared to Pyocyanin alone (p ≤ 0.05). In conclusion, S. boulardii supported microbiota homeostasis by suppressing TLR4/NF-κB signaling, whereas Pyocyanin exacerbated the inflammatory response via NLRP3 activation. These findings provide molecular evidence supporting probiotic-assisted immunomodulatory strategies in sepsis therapy.